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Chaprer 7
Multiple sclerosis (MS) is the most well-known demyelinating disease in hurnans. Although its
main cause is sti l l  not known, environmental (viral infections), autoimmunity and gcnetic factors
have been implicated in the etiology of MS. Therefore, an el'fective therapy Íbl MS is not
available yet, but cuÍrent treatments are directed toward preventing myelin breakclown via
suppression of the immune system. However, promotion of myelin repair via remyclination-
based strategies after or during treatment of the inflammatory response may bccorne eclually
irnportant. To promote remyelination in MS lesions via either endogenous or transplantcd
oligodendrocyte progenitors, it is necessary that oligodendrocyte progenitors rnigrate. plolilèratc
and eventually differentiate to mature myelinating oligodendrocytes at the sitc of the MS lesion.
Alternatively, remyelination by the remaining mature oligodendrocytes may be indLrced. To
guide (re)myelination in MS lesions and to obtain an eÍfective remyelination-basccl therapy. it is
imperative to understand the key events in the process of myelination. Such events incluclc the
extracellular and subsequently activated intracellular events that are important during
oligodendrocyte differentiation and the onset of myelination. The goul of the project, clescribed
in this thesis, was therefore to study the involvernent of both extracellular ancl intraccllular
signals in oligodendrocyte l ineage progression.
Intracellular signaling: PKC signal transduction pathway
In rats, oligodendrocyte progenitors migrate, proliferate and difÍèrentiate hr vit,o according to
a precise schedule over a period of several weeks in order to myelinate axons i it the
appropriate time and place. This implies a tightly controlled mechanism in ordcr to pre\rent
premature and nonessential diffbrentiation. The study described in chapter 2 showed that thc
protein kinase C (PKC) signaling route is an important negative modulator in the regr-rlation of
the switch to differentiation. We also demonstrated that activation of PKC prevents
(premature) oligodendrocyte differentiation, whereas further differentiation toward
myelinating oligodendrocytes is dependent on other signals, l ike elevation of cAMP levels,
which may counteract the PKC signal transduction pathw ay. In chapter J it was revealed how
activation of PKC keeps the oligodendrocyte progenitors arrested in the pro-oligodendrocyte
stage. This is accomplished by regulation of the actin cytoskeleton structuring via
phosphorylation of myristoylated alanine-rich C-kinase substrate (MARCKS). Upon PKC-
mediated phosphorylation, MARCKS was translocated from the plasma rnembrane to the
cytosol, and consequently no longer capable of regulating actin-membrane interactions. As a
result, actin filaments are redistributed to the submembranous or cortical actin cytoskeleton,
which caused an impediment of plasma membrane-directed traffic of 'basolateral'-sorted
proteins. On the other hand, under the same conditions, PKC activation stirnulated the
transport of 'apical'-predestined proteins to specific sites just underneath the plasma
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polarized trafficking pathways, as direct perturbation of the actin cytoskeleton perturbation
did not interfere with the translocation of 'apical'- l ike proteins. Final incorporation into the
plasma membrane might be hindered by a lack of appropriate docking devices in
oli godendrocyte progenitors.
Extracellular signaling: PDGF and bFGF signal transduction pathways
To establish the physiological relevance of the PKC-related effects, we investigated whether or
not inhibiton of oligodendrocyte differentiation by platelet-derived growth factor (PDGF) or
basic fibroblast growth factor (bFGF) was related to PKC activation. In clnpter 4, iÍ is
described that both PDGF and bFGF induce phosphorylation and translocation of the PKC
substrate, MARCKS, and as a consequence induce redistribution of actin fi laments to the
cortical actin cytoskeleton. This indicates that PKC activity is instrumental in inhibit ing
oligodendrocyte differentiation by both growth factors. Yet, since the induction of
proliferation was not PKC-mediated, differentiation was still inhibited after pre-treatment
with PKC-specific inhibitors. Hence, to induce differentiation in PDGF- or bFGF-activated
oligodendrocyte progenitors a simultaneous abrogation of the growth factor-induced
proliferative activity is necessary. The mitogenic activity of PDGF and bFGF was blocked by
pre-exposure to inhibitors of p42/p44 mitogen-activated protein kinase (MAPK), p38 MAPK,
and pp70 56 kinase, while the activity of these kinases was essential for the onset of
oligodendrocyte differentiation as well. We suggest therefore, that oligodendrocyte lineage
progression is regulated by independent signaling pathways, acting in parallel and steering
mitogenic activity and/or differentiation arrest. As a consequence, oligodendrocyte
maturation, and subsequently myelination, is accomplished by the action of two or more
signals acting in concert that counteract PDGF- and/or bFGF-activated signaling pathways.
Such a signal could be cAMP-dependent kinase (PKA)-mediated, as PKA activation was able
to partly abolish the prcliferative activity of bFGF.
Signaling in an in vitro myelinating culture
To study the significance of regulation of oligodendrocyte differer.rtiation via modulation of
signaling events with respect o (re)myelination in MS lesions, we introduced and optimized
an ín vítro myelinating system derived from fetal rat brain. In these cultures astrocytes,
neurons and oligodendrocyte are present, and thereby mimicking the in vivo situation as
closely as possible. Using this in vitro myelinating system, we describe in chapter 5 that when
PKC or bFGF signaling routes were activated during development, oligodendrocyte
differentiation was inhibited. The expression of the late rnyelin-specific proteins MBP and
PLP was impeded, in contrast to the early myelin-specific proteins CNP and MAG that were
expressed. Accordingly, myelin formation was absent in these cultures. Surprisingly, myelin
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formation was also absent upon continuous occupancy of PDGF receptors cluring
development, even though CNP, MAG, MBP and PLP were expressed in normal amounts in
these cultures. This indicates that differentiation per se does not inherently lead to
myelination. We anticipate that this irt vitro myelinating system will proviclc further insight
into the regulation of differentiation and the onset of myelination. Preliminary experiments
have also shown that it is possible to design a demyelinating model of this lrr l i trc rnyelinating
system, thus allowing a detailed study of the signaling events required for rernyelination.
Identification of functional caveolae in the oligodendrocyte lineage
A mechanism to control asynchronous oligodendrocyte diffèrentiation may imply a localized
srgnaling via caveolae, which are known as organized signaling centers at the plasma
membrane of mammalian cells. In contrast o previous claims, the results describecl in chupter
ó demonstrate that caveolin- l, the major 'caveolar coat' protein, is expressed in a
oligodendrocytic ell l ine (OLN-93) and even in primary oligodendrocytes. albeit to a lesser
extent. Furthermore, we demonstrated that functional caveolae werc present in the
oligodendrocyte l ineage. However, electron microscopic analysis and cholera toxin subunit B
(CTB) internalization assays showed that not every cell in the oligodenclrocyte l ineage
assembled caveolae. Indeed, indirect immunofluorescence microscopy revealed that the
majority of caveolin-1 was intracellularly located in oligodendrocytes. In this regard, the data
indicate that functional assembly of caveolae is cell-cell contact-dependent. Therefore, it is
possible that the crit ically t imed regulation of oligodendrocyte differentiation is accomplished
via local and organized signaling in caveolae. Furthermore, since caveolin-1 and caveolae has
been implicated in polarized traffic events and given its intracellular localization, a role for
caveolin-1 in vesicular trafficking in the oligodendrocyte lineage is suggested.
General conclusions
Taken together, the studies described in this thesis have provided insight into the complex
regulation of oligodendrocyte l ineage progression. The results obtained can be summarized in
two fairly simplif ied models, describing (i) intracellular signaling events involved in
oligodendrocyte differentiation (fig. 1A) and (i i) the complex interplay between extracellular
and intracellular signaling events, leading to proliferation and/or differentiation (fig. 1B).
Briefly, oligodendrocyte differentiation can be blocked by PKC activation or by p42lp44
MAPK, p38 MAPK or pp70 56 kinase inhibit ion (fig. 1A). There seems to be no cross-talk
between signaling pathways activated by the particular PKC signaling route and these other
kinases. PKA activation can negatively interfere with PKC-mediated inhibit ion of
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Figure 1: schematic model of signaling factors involved in oligodendrocyte dffireníiation and./or prorifuration.Both models are based on results obtained in studies, described in this thásis. Á; intrac"rrua. signaling events in
:iË::ï::::íji.,ïiï::",ïLï:ï:;r:]";::ïïluru. u}uu,ion or intrace,,u,ar signa,ing events in borh
129
Chapter 7
differentiation occurs at least in part via PKC activation (fig. lB). Yet, differentiation has to
be accomplished by PKC inhibit ion, and a simultaneous abrogation of growth factor-induced
proliferation via inhibit ion of either p42lp44 MAPK, p38 MAPK, or pp70 56 kinase.
However, as these latter signaling molecules are also involved in the induction of
oligodendrocyte differentiation (fig. 1A), the length of the period of activation of these kinases
is probably important for determining whether proliferation or differentiation will take place.
Transient versus sustained activation can be accomplished via cross-talk with the PKA
signaling pathway, as PKA activation can induce oligodendrocyte differentiation to the next
developmental stage in PDGF-treated progenitors, and significantly inhibits bFGF-mediated
proliferation.
Insight has also been obtained with respect to possible approaches in the development of
remyelination-based strategies. Although studies were performed with rat-derived cultures, the
results obtained will certainly facilitate research in human. The absence of a signil'icant degree
of spontaneous remyelination in MS lesions may be due to either the presence of inhibitory
factors preventing myelin repair or the absence of cells or factors necessary for de novo
myelin synthesis. Possibly, a combination of signaling factors, l ikely including PKC-
inhibitors, might be beneficial to the treatment of MS in the (near-)future. Sti l l , extensive
work is necessary to further elucidate the most promising set of signaling factors, capable of
inducing (re)myelination in MS lesions. Not only the signaling factors involved in
proliferation and differentiation of oligodendrocyte progenitors, but also those involved in
migration and survival of oligodendrocytes are of crucial importance in this respect.
Perspectives
Future fundamental experimental research should be focused on the interaction between
different signaling pathways, which provides specific and precisely timed regr-rlation of
oligodendrocyte differentiation. The essential asynchronous differentiation of
oligodendrocytes is probably accomplished via integration of general and local signals, such
as those exerted by astrocytes or neurons. Localized signaling, as a modulator of
oligodendrocyte l ineage progression, provides a means by which the intrinsic diÍferentiation
pathway can be modulated according to the need for oligodendrocytes at any particular
location. Specifically, the cross-talk between growth factor- and integrin-mediated signaling
in oligodendrocytes needs to be further explored, since the same signaling molecules as those
in grclwth factor signal transduction pathways were activated upon extracellular matrix (ECM)
binding and integrin clustering (Juliano, 1996). Furthermore, an indication that integrin-
mediated signaling may play a significant role in modulating oligodendrocyte differentiation,
is dictated by the switching of integrin B subunits during differentiation (Milner and ffrench-
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of oligodendrocytes may trigger oligodendrocyte differentiation (Malek-Hedayat and Rome,
1994, Pesheva et al., 1997). Hence, triggering of integrin-induced signaling cascades may
affect, or even counteract the effect of PDGF and bFGF on oligodendrocyte differentiation
arrest. Alternatively, an interplay between growth factor- and hormone-mediated signaling
may modulate the switch to oligodendrocyte differentiation. Barres et al. (1994b) reported that
hydrophobic signals, like thyroid hormone (T3), glucocorticoids and retinoic acid, are
responsible for timing oligodendrocyte differentiation by counteracting the differentiation
arrest induced by mitogenic growth factors. As these hydrophobic signals bind directly to
intracellular receptors that activate transcription, a cross-talk between these signaling
pathways on a transcriptional evel is l ikely. Interestingly, these hydrophobic signaling
molecules share the ability with PKC, PDGF and bFGF to modulate the activity of the
transcription factor, activator protein-l (AP-1). It wil l be of particular interest, therefore, to
examine the effects of PKC-, bFGF- or PDGF-activated signaling rolltes, alone or in
combination with hydrophobic signals, on transcriptional activity.
Another intriguing question for future research is whether PKA activation is of physiological
significance in the timing of oligodendrocyte differentiation. In this thesis, evidence has been
provided that PKA activation can partially counteract PKC-mediated arrest of oligodendrocyte
differentiation and bFGF-induced proliferation. Furthermore, Raible and McMorris (1993)
have shown that PKA independently upregulates the rate of differentiation of oligodendrocyte
progenitors, and inhibits their proliferation without changing lineage commitment. Therefore,
the identification of extracellular upstream signaling events in relation to PKA activation will
contribute to the unraveling of signaling events involved in the timing of oligodendrocyte
differentiation. In this respect, and also in the context of facilitation of (re)myelination, more
attention should be paid to signaling events exerted by other positive modulators of
oligodendrocyte differentiation, including insulin-like growth factor (IGF, McMorris and
Dubois-Dalcq, 1988) and ceramide (our unpublished observations).
To elucidate the exact sequence of molecular events in oligodendrocyte differentiation and the
onset of myelination, the availability of appropriate model systems will be imperative. The in
vitro myelinating system described in this thesis (chapter 5) may be a valuable tool in the
characterization of these events. Ultimately, this knowledge of signaling events, important for
the onset of myelination, may lead to a promising strategy to promote myelin repair in MS
lesions.
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